Stichworte
Schizophrenie ×
Zeige mehr Stichworte
Inhaltsverzeichnis
  1. 1. Klinische Studie
  2. 2. Routinedokumentation
  3. 3. Register-/Kohortenstudien
  4. 4. Qualitätssicherung
  5. 5. Datenstandard
  6. 6. Patientenfragebogen
  7. 7. Medizinische Fachrichtung
Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

277 Suchergebnisse.

Eligibility Social Cognition in Patients With Schizophrenia NCT02440867

- 22.01.19 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Treating Social Cognition With Theta Burst Stimulation; a Pilot Sudy; ODM derived from: https://clinicaltrials.gov/show/NCT02440867

Eligibility Schizophrenia NCT02453893

- 21.01.19 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT02453893

Eligibility Schizophrenia NCT02400502

- 21.01.19 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Integrated Coping and Awareness Training; ODM derived from: https://clinicaltrials.gov/show/NCT02400502

Eligibility Schizophrenia NCT01869660

- 21.01.19 - 1 Formular, 2 Itemgruppen, 8 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Shared Decision Making for Patients With First-admission Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01869660

Eligibility Schizophrenia NCT01795183

- 20.01.19 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Criteria, Exclusion Criteria
Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01795183

Eligibility Schizophrenia NCT01636037

- 20.01.19 - 1 Formular, 2 Itemgruppen, 7 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Antipsychotic Augmentation With L-Dopa; ODM derived from: https://clinicaltrials.gov/show/NCT01636037

Eligibility Schizophrenia NCT01563016

- 20.01.19 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Glucose as a Mediator of Self-control Performances in Patients With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01563016

Eligibility Schizophrenia NCT01376076

- 20.01.19 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01376076

Eligibility Schizophrenia NCT01192906

- 20.01.19 - 1 Formular, 2 Itemgruppen, 8 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309); ODM derived from: https://clinicaltrials.gov/show/NCT01192906

Eligibility Schizophrenia NCT01192880

- 19.01.19 - 1 Formular, 2 Itemgruppen, 8 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25308); ODM derived from: https://clinicaltrials.gov/show/NCT01192880

Eligibility Schizophrenia NCT01192867

- 19.01.19 - 1 Formular, 2 Itemgruppen, 8 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
A Study of RO4917838 in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310); ODM derived from: https://clinicaltrials.gov/show/NCT01192867

Eligibility Schizophrenia NCT02086162

- 19.01.19 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Randomized Controlled Trial (RCT) of a Motivational Decision Support System; ODM derived from: https://clinicaltrials.gov/show/NCT02086162